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Major involvement of CD40 in the regulation of chemokine
secretion from human peritoneal mesothelial cells.
Background. CD40 is a member of the tumor necrosis factor
(TNF) family of receptors, whose ligand, CD154, is expressed
by activated mononuclear cells. CD40 activation is a major im-
mune regulatory pathway and is important for the regulation of
chemokine and cytokine secretion. This study investigates the
effect of CD40 ligation on the secretion of chemokines from
human peritoneal mesothelial cells (HPMC).
Methods. We activated CD40 in HPMC along with combi-
nations of TNF-a, interleukin-1 (IL-1), and interferon gamma
(IFN-c ), and evaluated the mRNA levels and protein secre-
tion of regulated upon activation, normal T-cell expressed
and secreted (RANTES), monocyte chemoattractant protein-1
(MCP-1), and IL-8.
Results. CD40 ligation had a small stimulatory effect on the
secretion of all three chemokines, while TNF-a, IL-1 and IFN-c
induced their secretion in a dose-dependent manner. The com-
bination of CD40 ligation with either IL-1 or TNF-a increased
chemokine secretion additively. IFN-c and CD40 ligation acted
in synergy to induce the secretion of the mononuclear recruit-
ing chemokines RANTES and MCP-1 (up to ∼36-fold and ∼
threefold, respectively), for which the combination of all three
cytokines with CD40 ligation was extremely potent. In contrast,
the secretion of the neutrophil chemoattractant IL-8, induced
by CD40 ligation or by the combination of IL-1 and TNF-a, was
reduced in the presence of IFN-c .
Conclusion. In light of our data, it is reasonable to suggest
that in the mononuclear phase of peritonitis, IFN-c and CD154,
expressed by activated mononuclear cells, diminish IL-8 secre-
tion from HPMC and thus inhibit neutrophil recruitment. At
the same time, the two act in synergy to induce the secretion
of RANTES and MCP-1 from HPMC. Hence, by regulating
chemokine secretion, CD40 may be involved in peritonitis and
in the development of late phase mononuclear predominance.
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During peritonitis, mesothelial cells gate leukocyte
trafficking into the peritoneal compartment [1]. Con-
sistent with this role, following inflammation in vivo or
cytokine stimulation in vitro, human peritoneal mesothe-
lial cells (HPMC) up-regulate the expression of
intracellular adhesion molecule-1 (ICAM-1) and vas-
cular cell adhesion molecule-1 (VCAM-1) [2–5], and
respond to bacterial and inflammatory mediators by
secreting proinflammatory cytokines and chemokines
[6–11].
The early leukocytic influx during peritonitis is part
of the nonspecific innate immune response and con-
sists predominantly of neutrophils [10]. It is followed
shortly by a mononuclear infiltrate, which is part of
the specific immune response [10]. “Switching” between
infiltrate phenotypes is important for a successful im-
mune response and is a tightly regulated process. It
has been suggested that the regulation of the infiltrate
phenotype is controlled by chemokine secretion from
mesothelial cells [12]. Cytokine-activated HPMC have
been shown to secrete both neutrophil-specific CXC
[interleukin-8 (IL-8)] and mononuclear-specific CC [reg-
ulated upon activation, normal T-cell expressed and
secreted (RANTES) and monocyte chemoattractant pro-
tein (MCP)-1] chemokines [7]. In addition, specific anti-
body blocking studies have demonstrated a direct role for
HPMC-derived IL-8 and MCP-1 in mediating leukocyte
migration of appropriate phenotypes across the mesothe-
lial layer [12].
CD40 is a cell surface receptor that belongs to the
tumor necrosis factor (TNF)-receptor family (reviewed
in [13]). Its critical role in T-cell–dependent immune re-
sponses has been demonstrated in patients with hyper-
IgM syndrome, as well as by gene targeting in mice.
The CD40 receptor is expressed on B cells and mono-
cytes, and on dendritic, endothelial, and epithelial cells.
We recently demonstrated that mesothelial cells express
CD40 [14]. The ligand for the CD40 receptor, CD154, is
a member of the TNF family and is mainly expressed on
activated CD4+ T cells. Unlike soluble TNF-a, CD154
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acts as a membrane-bound ligand. Thus, using CD154 via
direct cell-to-cell contact, lymphocytes activate CD40 on
their target cells to induce the secretion of cytokines and
chemokines and to up-regulate the expression of adhe-
sion and accessory molecules.
Based on the effect of CD40 activation on chemokine
secretion from several tissues [15–21], and our finding
of a functional CD40 receptor on HPMC [14], we hy-
pothesized that the CD40 signaling may be involved in
the regulation of the chemotactic activity of HPMC and
thus affect the trafficking of immune cells into the peri-
toneal cavity. In support of this hypothesis, we recently
reported an inducible expression of the CD40 receptor
on the peritoneal membrane in a mouse model of gram-
positive and gram-negative bacterial peritonitis (submit-
ted for publication), as well as a gradual increase in
CD154 expression on infiltrating leukocytes in the same
model.
We therefore investigated whether CD40 ligation in
HPMC is involved in the regulation of leukocyte-specific
chemokine secretion from activated HPMC. We stim-
ulated HPMC using CD40 ligation in the presence of
IL-1, TNF-a, and interferon-gamma (IFN-c ), which are
cytokines that are involved in peritonitis [22, 23]. The
resulting changes in the production and secretion of
RANTES, MCP-1, and IL-8, chemokines that are in-
volved in leukocyte recruitment in peritonitis [24–27]
were then examined.
METHODS
Cell preparation
HPMC. Omentum-derived HPMC were isolated and
characterized for their specific morphology and markers,
as previously reported [28]. Experiments were performed
on cells from the second to fourth passages.
CD154-expressing L cells (CD40L cells)
For CD40 activation, we used a cell line of mouse fi-
broblast L cells, transfected with the complete human
CD154 coding sequence and a neomycin resistance gene
for selection of stable transfectants. Both types of cells
were cultured in RPMI and supplemented with 10% heat-
inactivated fetal calf serum (FCS), 2 mmol/L L-glutamine,
100 U/mL penicillin, and 100 lg/mL streptomycin
(Biological Industries, Bet Haemek, Israel). The parental
nontransfected cells (L cells) were used as a negative
control. Both parental and CD154-transfected cells were
kindly supplied by Schering Plough Corporation and
have been previously described [29]. CD40 activation us-
ing CD154 expressing cells is frequently used to activate
CD40 on various cell types in several experimental mod-
els [29–32].
HPMC activation protocols
HPMC were seeded in 24-well plates (2 × 104 cells/
well) and cultured to confluence. HPMC were washed
twice with medium and incubated with TNF-a (Pepro-
tech, Rocky Hill, NJ, USA), IL-1a (kindly provided by
Hoffman-La Roche, Nutley, NJ, USA), or IFN-c (Pepro-
tech) in various concentrations, and with CD40L cells
(expressing CD154) or control L cells (5 × 104). The in-
cubation time for chemokine determination was 24 hours
for enzyme-linked immunosorbent assay (ELISA) anal-
ysis, and 6 hours for mRNA analysis. Incubation time
for RNA analysis was optimized in preliminary experi-
ments. To prevent overgrowth of L cells and CD40L cells
in the co-culture experiments, the cells were grown in
M-199 medium, which inhibits fibroblast growth. Super-
natant was collected and stored at −20◦C. Cells from two
wells were counted in each plate to determine consistency
of cell number per well. All tissue culture reagents con-
tained less than 0.025 ng/mL endotoxin. As a positive con-
trol for stimulation for IL-1b production, HPMC were
stimulated with IL-1a (100 U/mL), TNF-a (10 ng/mL),
and lipopolysaccharide (LPS) (10 lg/mL) (Sigma,
Rehovot, Israel).
mRNA analysis
IL-8, MCP-1, and RANTES mRNA were determined
by reverse transcription-polymerase chain reaction
(RT-PCR) of total RNA extracted from HPMC. HPMC
were incubated as described above. At the end of each
experiment, murine cells were discarded and their ab-
sence was confirmed under light microscopy. Total RNA
was extracted from HPMC using the RNeasy Mini Kit
(Qiagen, Hilden, Germany). The extracted RNA was im-
mediately converted to cDNA. For cDNA generation,
13 lL of RNA sample were added to 7 lL reverse tran-
scriptase reaction mixture, containing 1 lL of Moloney
murine leukemia virus-reverse transcriptase (MMLV-
RT) (200 U/lL) (Gibco BRL, Gaithersburg, MD, USA),
4 lL reverse transcriptase buffer (Gibco BRL), 0.5 lL
dithiothreitol (DTT) (0.1 mol/L) (Gibco BRL), 0.5 lL
RNase inhibitor (40 U/lL) (Sigma), 1 lL oligo-d(T) 12–
18 mer (40 pmol/lL) (Roche), and 1 lL desoxynucleoside
triphosphate (dNTP) (10 nmol/lL) (Sigma). The reaction
tube was incubated for 1 hour at 37◦C, after which the vol-
ume of each sample was adjusted to 60 lL and the enzyme
was inactivated by incubation for 10 minutes at 65◦C.
Chemokines and b-actin cDNA were amplified by PCR
using specific primers. RANTES sense TCT CCA CAG
GTA CCA TGA AGG, RANTES antisense GGT TCA
AGG ACT CTC CAT CC; MCP-1 sense TTG TGT GCC
TGC TGC TCA TA, MCP-1 antisense GGT TTG CTT
GTC CAG GTG GT; IL-8 sense TGA CTT CAA AGC
TGG CCG TG, IL-8 antisense CCA CGT CTC CAA
CAC CTC T; and b-actin sense ATG GAT GAT GAT
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ATC GCC GCG, b-actin antisense CTA GAA GCA TTT
GCG GTG GAC GAT GGA GGG GCC. The primers
were designed to be specific for human cDNA. A total of
5 lL of reverse transcription product were added to
45 lL of PCR reaction mixture containing 32.75 lL H2O,
2.5 lL 5′ primer (20 lmol/L), 2.5 lL 3′ primer (20 lmol/L),
2 lL dNTP (10 nmol/lL) (Sigma), 5 lL reaction buffer,
and 0.25 lL Taq DNA polymerase (Sigma). A negative
control consisting of the reaction mixture without cDNA
was included in each run. PCR was run for 20 to 25 cy-
cles with b-actin primers under the following conditions:
90 seconds at 95◦C, then 5 to 10 cycles of 45 seconds each
at 95◦C, 90 seconds at 60◦C, and 1 minute at 72◦ C. The last
15 cycles were prolonged by 5 seconds in each cycle. PCR
with RANTES, MCP-1, or IL-8 primers was run with the
same protocol except that the number of cycles was 30 to
35, 20 to 25, 25 to 30, respectively. Each experiment was
amplified with at least two different numbers of cycles
to ensure that amplification was in the exponential phase
of PCR. Under these conditions, we also found a linear
dose-response of the PCR product to increasing doses of
cDNA.
Eight microliters of each sample containing amplified
cDNA were loaded on an agarose gel (1.5%) containing
ethidium bromide (0.5 lg/mL). A DNA size marker was
run on the same gel (100 bp ladder) (Gibco BRL). PCR
products were quantified by video densitometry with the
ImageMaster VDS-CL (Amersham Pharmacia Biotech,
Freiburg, Germany). To correct for differences in load-
ing, densitometric values of RANTES, MCP-1, and IL-8
amplification products were corrected with correspond-
ing values of b-actin.
ELISA
IL-8, MCP-1, RANTES, and IL-1b were measured
in supernatants in duplicates using ELISA for human
IL-8, MCP-1, RANTES, and IL-1b made with commer-
cially available antibodies and standards (R&D Systems,
Minneapolis, MN, USA). ELISA was performed accord-
ing to the manufacturer’s protocol. The ELISAs are
specific for human products, have no cross-reactivity,
and exhibit no interference with 50 ng/mL of equiv-
alent murine products. For RANTES, we used mono-
clonal antihuman RANTES (4 lg/mL, type MAB678),
rhRANTES (39 to 2500 pg/mL), and biotinylated mono-
clonal antihuman RANTES antibody (200 ng/mL) (type
BAF278). For MCP-1, we used monoclonal antihuman
MCP-1 (4 lg/mL) (type MAB679), rhMCP-1 (31.25 to
2000 pg/mL) and biotinylated monoclonal antihuman
MCP-1 antibody (50 ng/mL) (type BAF279). For IL-8,
we used monoclonal antihuman IL-8 (4 lg/mL) (890804
DuoSet), rhIL-8 (31.25 to 2000 pg/mL), and biotiny-
lated monoclonal antihuman IL-8 antibody (20 ng/mL)
(890805 DuoSet). For IL-1b , we used mouse antihuman
IL-1b (4 lg/mL) (840168 DuoSet), rhIL-1b (3.1 to 250 pg/
mL) and biotinylated goat antihuman IL-1b antibody
(100 ng/mL) (840169 DuoSet). For detection we used
streptavidin horseradish peroxidase (HRP) (type 43-
4323) (Zymed, San Francisco, CA, USA) (1:20,000)
and tetramethylbenzidine solution (TMBSingle Solu-
tion) (Zymed). ELISA reaction was stopped with H2SO4
(2 N). Optical density was read with an ELISA reader
at 450 nm and at 550 nm for reference. The sensitivity
was 2 pg/mL. No cross-detection of other cytokines was
observed.
Statistics
Results are expressed as mean ± SD. To compare lev-
els between groups we used one-way analysis of vari-
ance (ANOVA). P values below 0.05 were considered
significant.
RESULTS
All of the experiments in this study were performed
on primary cultures of HPMC. The CD40 pathway was
activated in these cells by exposure to a murine cell line
genetically modified to express human CD154 (CD40L
cells). The use of these cells has been validated in pre-
vious reports [14, 30]. We previously demonstrated that
the interaction between these two cell populations is de-
pendent on cell-to-cell contact [14]. We used modified
murine cells, rather than activated lymphocytes, in or-
der to isolate the role of CD154 from other lymphocytic
signals. We also examined a soluble form of CD154 and
found a similar trend of HPMC activation, but with di-
minished response amplitude (data not shown). Since the
activation via cell-to-cell contact more accurately reflects
the physiologic manner of HPMC activation, we chose to
use the modified murine cell line for CD40 ligation.
We activated the CD40 pathway with CD154 express-
ing murine cells (CD40L cells) and different combi-
nations of TNF-a (0.001 to 10 ng/mL), IL-1 (0.01 to
100 U/mL), and IFN-c (0.05 to 500 U/mL). Following
stimulation, the secretion of chemokines was assayed
by ELISA and their mRNA levels were evaluated by
RT-PCR.
RANTES secretion (Fig. 1A) was induced by IL-1 or
TNF-a in a dose-dependent manner and was augmented
with the addition of CD154 (up to ∼1.6- and ∼2.4-fold,
respectively, at the maximal cytokine dose). IFN-c alone
had a small effect on RANTES secretion, but exhib-
ited an impressive synergistic increase when combined
with CD40 ligation (up to ∼36-fold). This effect was
also observed when examining mRNA levels. RANTES
mRNA levels following CD40 ligation and IFN-c stimu-
lation could be detected following 30 amplification cycles,
while five additional amplification cycles were needed to
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Fig. 1. Effect of CD40 ligation on chemokine secretion from human peritoneal mesothelial cells (HPMC) in the presence of tumor necrosis factor-a
(TNF-a ), interleukin-1 (IL-1), or interferon-gamma (IFN-c ). Primary cultures of HMPC (2 × 104 cells/well) were incubated for 24 hours in the
presence of varying concentrations of IL-1, TNF-a, or IFN-c (left, middle, and right panels, respectively) and were added either CD40L-expressing
murine fibroblasts () or control L cells (4 × 105 cells/well) (). Levels of regulated upon activation, normal T-cell expressed and secreted (RANTES)
(A), monocyte chemoattractant protein-1 (MCP-1) (B), and interleukin-8 (IL-8) (C) were assayed by specific enzyme-linked immunosorbent assay
(ELISA). Results are average values ± SD of three experiments performed in triplicate. ∗P < 0.05; ∗∗P < 0.01; ∗∗∗P < 0.005 versus the same
experimental conditions without CD40 ligation; Pˆ < 0.05 versus the same experimental conditions without IFN-c .
detect RANTES levels in control and in single treatment,
reflecting the extent of induction by CD40 ligation and
IFN-c (Fig. 2). IFN-c induction of RANTES secretion
was also synergistic with TNF-a (∼59-fold) (Fig. 3). Max-
imal RANTES secretion was obtained by the combina-
tion of CD154, TNF-a, and IFN-c (∼69-fold). For all
combinations of TNFa, IL-1, and IFNc , CD40-ligation
significantly increased RANTES secretion (Fig. 3).
MCP-1 secretion (Fig. 1B) was achieved in the presence
of each cytokine alone in a dose-dependent manner. IL-1
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Fig. 2. Effect of interferon-gamma (IFN-c ) and CD40 ligation on
chemokine mRNA levels in human peritoneal mesothelial cells
(HPMC). Primary cultures of HMPC (2 × 104 cells/well) were in-
cubated for 6 hours in the presence of IFN-c (5 U/mL) or CD40L-
expressing murine fibroblasts (4 × 105 cells/well) or both. Reverse
transcription-polymerase chain reaction (RT-PCR) was performed with
specific primers for regulated upon activation, normal T-cell expressed
and secreted (RANTES), monocyte chemoattractant protein-1 (MCP-
1), interleukin-8 (IL-8), and b-actin and the products were run on 1.5%
agarose gels containing ethidium bromide. Gels are presented in the
left panels. The PCR products shown here are 30 and 35 amplification
cycles (Cy) for RANTES, 25 cycles for MCP-1, and 30 cycles for IL-8.
The right panel shows the intensity of the PCR products evaluated by
video densitometry and normalized according to their b-actin levels.
RANTES densitometry was performed on products after 35 cycles of
PCR. Unstimulated control was normalized to 1 and the densitometry
of all other samples were adjusted accordingly. Results are average val-
ues ± SD from four independent experiments performed in triplicate.
∗P < 0.05 versus untreated control (CT).
or TNF-a exhibited an additive increase in secreted levels
when combined with CD154. IFN-c induction of MCP-1
secretion was synergistic with CD154 (∼3-fold). CD40
ligation had no additional effect on TNF-a and IL-1 in
the presence of IFN-c (Fig. 3).
IL-8 secretion (Fig. 1C) was achieved to a small extent
by IL-1 and TNF-a and was increased in the presence
of CD154 (IL-1 ∼2.0-fold and TNF-a ∼1.3-fold). IFN-c
had a negative dose dependent effect on the levels of IL-8
and was able to significantly diminish the effect of CD40
at concentrations higher than 5 u/mL. The most effective
combination to achieve IL-8 secretion was CD40 ligation
in the presence of TNF-a and IL-1. Any combination
containing IFN-c diminished IL-8 secretion levels
(Fig. 3). CD40 ligation had no additional effect when
TNF-a, IL-1, and IFN-c were combined (Fig. 3).
Since we previously demonstrated that stimulation of
HPMC with inflammatory agents resulted in induction
of IL-1 [6], we tested whether IL-1 secretion is affected
by CD40 ligation. We found that in contrast to the posi-
tive control for IL-1b induction, namely, stimulation with
TNF-a, IL-1a, and LPS, HPMC exposed to CD40 L cells
for 24 hours did not produce significant levels of IL-1b
(Fig. 4).
DISCUSSION
The present study supports our contention that CD40
has a regulatory role in the secretion of chemokines
from HPMC. We demonstrated that when stimulated by
TNF-a, IL-1, or IFN-c , secretion of the mononuclear
specific chemokine, RANTES, by HPMC is up-regulated
in the presence of CD154, the CD40 ligand. This phe-
nomenon was particularly evident when HPMC were
stimulated by a combination of IFN-c and CD154, which
magnified secretion of RANTES by up to 59-fold. As
we suspected that mesothelial cells are exposed to both
CD154 and IFN-c at the point of mononuclear infiltra-
tion, rather than pretreating them with IFN-c , we simul-
taneously administered CD154 and IFN-c throughout
the study. A similar pattern of RANTES secretion in the
presence of CD154 and IFN-c has been described in a
cervical cancer cell line [32] and in myocytes [33]. We
also demonstrated that RANTES secretion was induced
by up to 69-fold when mesothelial cells were treated with
a combination of TNF-a, IFN-c , and CD154. Similar to
RANTES, we found that secretion of another mononu-
clear specific chemokine, MCP-1, was up-regulated when
HPMC were treated with TNF-a, IL-1, or IFN-c in the
presence of CD154. A possible mechanism by which
IFN-c and TNF-a increases the effect of CD40 ligation
is by up-regulating CD40 levels on HPMC, as we have
previously described [14]. Another mechanism for the
synergism of CD40 and IFN-c is inferred by the find-
ings of Genin et al [34] who have shown that optimal
RANTES expression is attained by the cooperative ac-
tions of the transcription factors nuclear factor-kappaB
(NF-jB) and IFN-regulatory factor-1 (IRF-1) [34]. Since
CD40 activates NF-jB [13] and IFN-c activates IRF-1
[35], these transcription factors may play a major role in
the synergistic induction of RANTES and MCP-1.
Similar to the up-regulatory effects on RANTES and
MCP-1, the secretion of IL-8 by mesothelial cells was
up-regulated by a combination of CD154 with TNF-a or
IL-1. In contrast, a significant down-regulatory effect on
IL-8 secretion was detected when the cells were treated
with IFN-c .
Our data demonstrate that the effects of CD40 ligation
on chemokine secretion by mesothelial cells are not me-
diated by IL-1 induction. We have previously shown that
HPMC produce IL-1 in response to various inflammatory
signals [6]. However, in the present study, CD40 ligation
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Fig. 3. Effect of CD40 ligation on chemokine
secretion from human peritoneal mesothelial
cells (HPMC) in the presence of various com-
binations of tumor necrosis factor-a (TNF-
a ), interleukin-1 (IL-1), and interferon-
gamma (IFN-c ). Primary cultures of HMPC
were incubated for 24 hours in the presence
of IL-1a (10 U/mL), TNF-a (1 ng/mL), and
IFN-c (5 U/mL) and were added 4 × 105
cells/well of either CD40L-expressing murine
fibroblasts () or control L cells (). Levels
of regulated upon activation, normal T-cell
expressed and secreted (RANTES), mono-
cyte chemoattractant protein-1 (MCP-1), and
IL-8 were assayed by specific enzyme-linked
immunosorbent assay (ELISA). Results are
average values±SD of three experiments per-
formed in triplicates. ∗P < 0.05; ∗∗∗P < 0.005
versus the same experimental condition with-
out CD40 ligation; Pˆ < 0.05 versus the same
experimental condition without IFN-c ; #P <
0.05 versus untreated control; ∼P < 0.05 com-
bined IL-1 and TNF-a versus IL-1 or TNF-a
alone.
did not induce IL-1 production, which suggests that the
effect of CD40 is direct.
CD40 has been associated with several conditions that
depend largely on the influx of a mononuclear infiltrate.
For example, in collagen-induced arthritis [36] and acute
and chronic graft rejection [37], anti-CD154 treatment al-
leviated disease parameters. Furthermore, we previously
reported that mesothelial cells express an inducible and
functional CD40 molecule [14]. We also demonstrated,
in a mouse model of bacterial peritonitis, that there is a
considerable induction of CD40 expression on mesothe-
lial cells during peritonitis (submitted for publication).
The involvement of CD40 in peritonitis is further sup-
ported by the finding of increased CD154 expression in
the mononuclear infiltrate in the same model. The timing
of CD154 elevation, 12 to 48 hours after initiation of peri-
tonitis (submitted for publication), which coincides with
CD40 up-regulation in mesothelial cells during peritoni-
tis and with the peak of the mononuclear infiltrate, also
supports the conjunction that CD40 is involved in cell
recruitment.
During peritonitis, the immunologic response is char-
acterized by the tightly orchestrated appearance of leuko-
cytes in the peritoneal compartment and a synchronized
secretion of proinflammatory cytokines [10]. This process
consists of two major phases of leukocyte infiltration: an
early phase of neutrophilic infiltration and a subsequent
phase in which mononuclear cells predominate [10]. Our
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Fig. 4. CD40 ligation does not induce interleukin-1 (IL-1) production
by human peritoneal mesothelial cells (HPMC). Primary cultures of
HMPC were incubated for 24 hours in the presence of either CD40L
expressing murine fibroblasts or control L cells. As a positive con-
trol for interleukin-1b (IL-1b) induction, HPMC were stimulated with
IL-1a (100 U/mL), tumor necrosis factor-a (TNF-a) (10 ng/mL), and
lipopolysaccharide (LPS) (10 lg/mL). IL-1b was assayed by specific
enzyme-linked immunosorbent assay (ELISA) (no cross-reactivity or
interference was observed when 50 ng/mL IL-1a was added in this as-
say). The figure is a representative experiment of two experiments per-
formed in triplicate. Results are presented as mean ± SD. ∗∗∗P < 0.005
versus untreated control.
results suggest that at the beginning of an immune re-
sponse in the peritoneum, mesothelial cells react to the
early cytokines TNF-a and IL-1 by elevating secretion of
chemokines that recruit granulocytes such as IL-8. In this
early phase, mononuclear cells are the minority of the
recruited cells. This could be the result of low IFN-c and
CD40 signals, which induce low RANTES and MCP-1
production. We found that the effects of CD40 ligation on
chemokine induction in the presence of TNF-a and IL-1
are negligible, which suggests that in the first phase of in-
flammation the CD40 signal has only a minor role. Hurst
et al [38] have reported that in the early phase of peri-
tonitis, IL-6 production by mesothelial cells is induced
and soluble IL-6 receptors (sIL-6R) are released from in-
filtrating neutrophils. They showed that mesothelial cells
have no IL-6 receptor, and therefore signaling of IL-6 in
mesothelial cells depends on granulocyte-sIL-6R. Most
significantly, they found that the IL-6 signal on mesothe-
lial cells down-regulates CXC chemokines and promotes
CC chemokines such as RANTES and MCP-1. As such,
by shedding sIL-6R, the influx of neutrophils induces its
own down-regulation and increases mononuclear cell in-
filtration [38]. The decline in granulocyte number at the
end of the first phase of inflammation probably results
in reduction of sIL-6R levels. Our data support the as-
sumption that at this point, when the IL-6 signal begins
to decline, maintenance of mononuclear cells infiltration
will be mainly dependent on the up-regulation of CD40
and IFN-c pathways. Thus, up-regulation of RANTES
and MCP-1 by the combination of CD154 and IFN-c
ensure the predominance of mononuclear cells at the
inflamed site. Our results also indicate that high levels
of IFN-c cause a decrease in IL-8 secretion from the
mesothelium, leading to a continuing decrease in neu-
trophil infiltration. The regulatory role of IFN-c that
we suggest here is consistent with the results of Topley,
Mackenzie, and Williams [10] who showed that IL-8 se-
cretion from mesothelial cells diminishes in the presence
of IFN-c , as well as those of Robson et al [39] who pro-
vided evidence that IFN-c affects the migration of neu-
trophils through the peritoneal membrane in vitro and in
vivo. The latter study, which focused on the effects of the
Th1-type cytokine IFN-c on leukocyte migration into the
peritoneum, also showed that stimulation of HPMC with
IFN-c alone or in combination with IL-1 or TNF-a up-
regulates MCP-1 and RANTES and inhibits IL-1– and
TNF-a–induced IL-8 secretion. Since both CD154 and
IFN-c are products of the mononuclear infiltrate, their
coordinated effect on CC and CXC chemokine secretion
from mesothelial cells indicates that in the late phase of
peritonitis mononuclear cells play a major role in the reg-
ulation of leukocyte recruitment.
CONCLUSION
We suggest that in the late phase of inflammation the
mononuclear signals IFN-c and CD40 suppress gran-
ulocyte recruitment and increases mononuclear migra-
tion via differential control of chemokine secretion by
mesothelial cells. This study provides further evidence
for the cellular crosstalk between mesothelial and im-
mune cells during peritonitis.
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